FDA Approves first Gene Therapy to treat adults with Hemophilia B

The FDA has officially approved Elon Musk’s Neuralink chip to proceed with human trials

Exciting News for SAS Programmers in Rare Disease Research!

We are thrilled to share some incredible updates from the TUNECT CRO team